Page 137 - Azerbaijan State University of Economics

THE JOURNAL OF ECONOMIC SCIENCES: THEORY AND PRACTICE, V.71, # 1, 2014, pp. 127-139

overall saving of 323,53 US$ per patient per year over all entities. The real cost saving without a

QALY saving effect would be at a 111,33 US$ per year. Taking into account, that no cost for the

telemedical measures were calculated and the service would include a 2-3 week phone call and a

telemedical care system worth a monthly fee of 15 US$ production cost, it turns out, that the

technology may not be able to save “real” cost in the system. A positive return would only be

generated over the additional QALY effect. Overall the technology could produce a QALY

effect of 8889 QALYs per year in the AR.

With the tool and methodology itself a custom-tailored health economic feasibility study

e.g. in terms of a specific population mix of the investigation and/or targeted outcome parameters

(e.g. saved cost at Provider, saved transportation cost, etc.) was produced. Additionally the

possibility of the implementation of a reinsurance model allows selective “risk adjustment” or a

nearly complete “buy out” of the risk of the new technology over an external reinsurance

provider. The designed reinsurance model is based exactly on the simulation model described in

this work and calculates the premium on an individually selectable risk algorithm basing on the

calculated underlying risks.

The whole simulation can only give a very rough overview on the potential savings and

effects of the technology – a big problem to get precise effects from the simulation is the fact of

the missing data: As there was only some cost data available and some epidemiology data was

completely missing for the specific distribution of CHF, the value simulated must been seen as a

“rough range” value. Positively speaking the tool and methodology can be used and integrated in

the development cycle of a new AR care program – as soon there is more evidence available, the

tool can simulate more precise results. New scientific evidence and market-related needs can be

137